Preview of healthcare startups participating in the Invest Digital Health Pitch Perfect competition
exist Invest in Digital Health The Sept. 18 conference in Dallas, where six startups will showcase their innovative technologies to try to meet unmet or inadequate needs in healthcare, as part of the PSTIGHT PERTICT conference. They will ask a team of investor judges who will ask a range of questions to challenge their business models and quantify their technology, strategy and path to market. Here is a preview of the finalists.
Algodx LLC Clinical decision support solutions have been developed, focusing on sepsis management, enhancing patient outcomes and reducing medical expenses in nursing settings. The company has offices in Cambridge, Massachusetts and Stockholm, Sweden. David Becedas is CEO.
Biotrillion, Inc. is an AI-powered health technology platform designed to convert smartphones into contactless health monitors. The MedTech company claims its technology can measure vital signs and digital biomarkers through 10-second selfie videos to facilitate early disease detection. Savan Devani is the founder and CEO of the San Francisco-based business.
pattern Flagship products use AI and optical feature recognition techniques to extract critical and relevant clinical history from complex patient recommendation data packets, and then generate a concise history of current disease and medical timelines. The company hopes to reduce clinical preparation time for doctors, nurse practitioners and their employees. Andrew Rogers is CEO and co-founder, based in Omaha, Nebraska.
D2Type is a comprehensive digital platform that helps people with type 2 diabetes and those with this condition. Its approach is committed to helping users make lifestyle changes to improve their health. Those using D2Type lower their weight and lower their risk of diabetes. It also utilizes health coaches and peer support groups. Co-founder Ameneh Madjd is headquartered in Vancouver, British Columbia.
Remmie, Inc. According to the company's website, a MedTech startup developed FDA-registered USB-SMART otoscopes for convenient home exams on mobile phones, tablets and computers. Remmie.ai and Remmie Apps capture and stream high-quality visuals for fast telemedicine and pre-visit assessments. Jane Zhang is founder and CEO, based in Seattle.
secestbio According to its LinkedIn page, the tumor microenvironment is decoded for precise oncology. Its AI/quantum platform aims to predict cancer metastasis and drug resistance, discover novel targets, and fuel therapies, starting with its SQT-101 antibody for triple-negative breast cancer (TNBC).
photo: MicrostockHub, Getty Images
